BACKGROUND: Studies of hospitalized patients identify safety as a significant problem, but few data are available regarding injuries occurring after discharge. Patients may be vulnerable during this transition period. OBJECTIVE: To describe the incidence, severity, preventability, and "ameliorability" of adverse events affecting patients after discharge from the hospital and to develop strategies for improving patient safety during this interval. DESIGN: Prospective cohort study. SETTING: A tertiary care academic hospital. PATIENTS: 400 consecutive patients discharged home from the general medical service. MEASUREMENTS: The three main outcomes were adverse events, defined as injuries occurring as a result of medical management; preventable adverse events, defined as adverse events judged to have been caused by an error; and ameliorable adverse events, defined as adverse events whose severity could have been decreased. Posthospital course was determined by performing a medical record review and a structured telephone interview approximately 3 weeks after each patient's discharge. Outcomes were determined by independent physician reviews. RESULTS: Seventy-six patients had adverse events after discharge (19% [95% CI, 15% to 23%]). Of these, 23 had preventable adverse events (6% [CI, 4% to 9%]) and 24 had ameliorable adverse events (6% [CI, 4% to 9%]). Three percent of injuries were serious laboratory abnormalities, 65% were symptoms, 30% were symptoms associated with a nonpermanent disability, and 3% were permanent disabilities. Adverse drug events were the most common type of adverse event (66% [CI, 55% to 76%]), followed by procedure-related injuries (17% [CI, 8% to 26%]). Of the 25 adverse events resulting in at least a nonpermanent disability, 12 were preventable (48% [CI, 28% to 68%]) and 6 were ameliorable (24% [CI, 7% to 41%]). CONCLUSION: Adverse events occurred frequently in the peridischarge period, and many could potentially have been prevented or ameliorated with simple strategies.
BACKGROUND: Studies of hospitalized patients identify safety as a significant problem, but few data are available regarding injuries occurring after discharge. Patients may be vulnerable during this transition period. OBJECTIVE: To describe the incidence, severity, preventability, and "ameliorability" of adverse events affecting patients after discharge from the hospital and to develop strategies for improving patient safety during this interval. DESIGN: Prospective cohort study. SETTING: A tertiary care academic hospital. PATIENTS: 400 consecutive patients discharged home from the general medical service. MEASUREMENTS: The three main outcomes were adverse events, defined as injuries occurring as a result of medical management; preventable adverse events, defined as adverse events judged to have been caused by an error; and ameliorable adverse events, defined as adverse events whose severity could have been decreased. Posthospital course was determined by performing a medical record review and a structured telephone interview approximately 3 weeks after each patient's discharge. Outcomes were determined by independent physician reviews. RESULTS: Seventy-six patients had adverse events after discharge (19% [95% CI, 15% to 23%]). Of these, 23 had preventable adverse events (6% [CI, 4% to 9%]) and 24 had ameliorable adverse events (6% [CI, 4% to 9%]). Three percent of injuries were serious laboratory abnormalities, 65% were symptoms, 30% were symptoms associated with a nonpermanent disability, and 3% were permanent disabilities. Adverse drug events were the most common type of adverse event (66% [CI, 55% to 76%]), followed by procedure-related injuries (17% [CI, 8% to 26%]). Of the 25 adverse events resulting in at least a nonpermanent disability, 12 were preventable (48% [CI, 28% to 68%]) and 6 were ameliorable (24% [CI, 7% to 41%]). CONCLUSION: Adverse events occurred frequently in the peridischarge period, and many could potentially have been prevented or ameliorated with simple strategies.
Authors: Jonathan S Lee; Anna Nápoles; Sunita Mutha; Eliseo J Pérez-Stable; Steven E Gregorich; Jennifer Livaudais-Toman; Leah S Karliner Journal: Patient Educ Couns Date: 2017-07-24
Authors: Sunil Kripalani; Terry A Jacobson; Ileko C Mugalla; Courtney R Cawthon; Kurt J Niesner; Viola Vaccarino Journal: J Hosp Med Date: 2010 May-Jun Impact factor: 2.960
Authors: Jerry H Gurwitz; Terry S Field; Jessica Ogarek; Jennifer Tjia; Sarah L Cutrona; Leslie R Harrold; Shawn J Gagne; Peggy Preusse; Jennifer L Donovan; Abir O Kanaan; George Reed; Lawrence Garber Journal: J Am Geriatr Soc Date: 2014-04-29 Impact factor: 5.562
Authors: Amna Al-Hashar; Ibrahim Al-Zakwani; Tommy Eriksson; Alaa Sarakbi; Badriya Al-Zadjali; Saif Al Mubaihsi; Mohammed Al Za'abi Journal: Int J Clin Pharm Date: 2018-05-12
Authors: Andrew D Auerbach; Sunil Kripalani; Eduard E Vasilevskis; Neil Sehgal; Peter K Lindenauer; Joshua P Metlay; Grant Fletcher; Gregory W Ruhnke; Scott A Flanders; Christopher Kim; Mark V Williams; Larissa Thomas; Vernon Giang; Shoshana J Herzig; Kanan Patel; W John Boscardin; Edmondo J Robinson; Jeffrey L Schnipper Journal: JAMA Intern Med Date: 2016-04 Impact factor: 21.873